Koalisjonen is a collaboration between ten pharmaceutical companies: Sanofi, Takeda, Biogen, BioMarin, Chiesi, Italfarmaco, Merck, Alexion, Lundbeck and CSL.
Since 2015, Koalisjonen has worked for predictable framework conditions for the treatment of rare diseases, through policy input, events and public debate. Koalisjonen works at system level and does not engage in matters concerning individual products.